Abstract
The efficacy and safety of drug-eluting stents compared with bare-metal stents remains controversial in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
| Original language | English |
|---|---|
| Pages (from-to) | 777-787 |
| Number of pages | 11 |
| Journal | JAMA - Journal of the American Medical Association |
| Volume | 308 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 22 Aug 2012 |
Keywords
- Absorbable Implants
- Aged
- Drug-Eluting Stents
- Female
- Humans
- Male
- Metals
- Middle Aged
- Myocardial Infarction
- Myocardial Ischemia
- Myocardial Reperfusion
- Myocardial Revascularization
- Polymers
- Prospective Studies
- Recurrence
- Risk
- Single-Blind Method
- Sirolimus
- Treatment Outcome
Fingerprint
Dive into the research topics of 'Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver